| payload |
{"created_at":"2026-04-10T11:10:59.787 {"created_at":"2026-04-10T11:10:59.787651+00:00","signal_type":"discovery_ipo_delta","source":"discovery_ingestor","url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOejdBYkRybE1KeGlfX0ZnWU9OMFR1UGpjWWR1XzhDVzRSOHlGTmhuQmZGT1FTeU9JTzZaWm1rQ3lMVFJpT2VPeXJodkdFR05fZFFHNXJ5QXlIWk02RWtxWHpvSTRLZm9yM2JhMnh6MDhvakIwOGgwQ0lvUDNqTDAxRS1fOUVxNndzamE4eEthaXkwNmJQRFhF?oc=5","value":{"fp":"9381260d5401e9bb","kind":"ipo_calendar","published_at":"2026-04-10T10:54:10+00:00","source":"The Pharma Letter","summary":"Avalyn targets Nasdaq IPO to fund late-stage push The Pharma Letter","tickers":[],"title":"Avalyn targets Nasdaq IPO to fund late-stage push - The Pharma Letter","url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOejdBYkRybE1KeGlfX0ZnWU9OMFR1UGpjWWR1XzhDVzRSOHlGTmhuQmZGT1FTeU9JTzZaWm1rQ3lMVFJpT2VPeXJodkdFR05fZFFHNXJ5QXlIWk02RWtxWHpvSTRLZm9yM2JhMnh6MDhvakIwOGgwQ0lvUDNqTDAxRS1fOUVxNndzamE4eEthaXkwNmJQRFhF?oc=5"}}... |